AAAAAA
Results:
1-25
|
Results: 25
Authors:
Volz, HP
Nenadic, I
Gaser, C
Rammsayer, T
Hager, F
Sauer, H
Citation: Hp. Volz et al., Time estimation in schizophrenia: an fMRI study at adjusted levels of difficulty, NEUROREPORT, 12(2), 2001, pp. 313-316
Authors:
Riehemann, S
Volz, HP
Stutzer, P
Smesny, S
Gaser, C
Sauer, H
Citation: S. Riehemann et al., Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test - a fMRI study, EUR ARCH PS, 251(2), 2001, pp. 66-71
Authors:
Moller, HJ
Volz, HP
Reimann, IW
Stoll, KD
Citation: Hj. Moller et al., Opipramol for the treatment of generalized anxiety disorder: A placebo-controlled trial including an alprazolam-treated group, J CL PSYCH, 21(1), 2001, pp. 59-65
Authors:
Smesny, S
Volz, HP
Liepert, J
Tauber, R
Hochstetter, A
Sauer, H
Citation: S. Smesny et al., Reptitive transcranial magnetic stimulation (rTMS) in acute and long-term treatment of therapy-resistant depression - a case report, NERVENARZT, 72(9), 2001, pp. 734-738
Authors:
Maurer, I
Volz, HP
Citation: I. Maurer et Hp. Volz, Cell-mediated side effects of psychopharmacological treatment, ARZNEI-FOR, 51(10), 2001, pp. 785-792
Authors:
Klemm, S
Rzanny, R
Riehemann, S
Volz, HP
Schmidt, B
Gerhard, UJ
Filz, C
Schonberg, A
Mentzel, HJ
Kaiser, WA
Blanz, B
Citation: S. Klemm et al., Cerebral phosphate metabolism in first-degree relatives of patients with schizophrenia, AM J PSYCHI, 158(6), 2001, pp. 958-960
Authors:
Sauer, H
Volz, HP
Citation: H. Sauer et Hp. Volz, Functional magnetic resonance imaging and magnetic resonance spectroscopy in schizophrenia, CUR OPIN P, 13(1), 2000, pp. 21-26
Authors:
Volz, HP
Moller, HJ
Reimann, I
Stoll, KD
Citation: Hp. Volz et al., Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial, EUR NEUROPS, 10(3), 2000, pp. 211-217
Authors:
Volz, HP
Gaser, C
Sauer, H
Citation: Hp. Volz et al., Supporting evidence for the model of cognitive dysmetria in schizophrenia - a structural magnetic resonance imaging study using deformation-based morphometry, SCHIZOPHR R, 46(1), 2000, pp. 45-56
Authors:
Volz, HP
Eberhardt, R
Grill, G
Citation: Hp. Volz et al., Efficacy and tolerance of the St. John's wort extract D-0496 in mild to moderate depression - a placebo-controlled, double blind 6-week trial, NERVENHEILK, 19(7), 2000, pp. 401-405
Authors:
Volz, HP
Sauer, H
Citation: Hp. Volz et H. Sauer, (31)Phosphorous magnetic resonance spectroscopic studies in schizophrenic patients, NERVENHEILK, 19(3), 2000, pp. 129-133
Authors:
Smesny, S
Volz, HP
Riehemann, S
Sauer, H
Citation: S. Smesny et al., Disturbances of phospholipidmetabolism - Possible pathogenic factors in schizophrenia. Survey and discussion of current findings, F NEUR PSYC, 68(7), 2000, pp. 301-312
Authors:
Riehemann, S
Volz, HP
Smesny, S
Hubner, G
Wenda, B
Rossger, G
Sauer, H
Citation: S. Riehemann et al., (31)Phosphorus magnetic resonance spectroscopy in schizophrenia research. On the pathophysiology of the cerebral high energy phosphate and membrane phospholipid metabolism, NERVENARZT, 71(5), 2000, pp. 354-363
Authors:
Volz, HP
Laux, P
Citation: Hp. Volz et P. Laux, Potential treatment for subthreshold and mild depression: A comparison of St. John's wort extracts and fluoxetine, COMP PSYCHI, 41(2), 2000, pp. 133-137
Authors:
Volz, HP
Riehemann, S
Maurer, I
Smesny, S
Sommer, M
Rzanny, R
Holstein, W
Czekalla, J
Sauer, H
Citation: Hp. Volz et al., Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: A P-31 chemical shift spectroscopic-imaging study, BIOL PSYCHI, 47(11), 2000, pp. 954-961
Authors:
Gaser, C
Volz, HP
Kiebel, S
Riehemann, S
Sauer, H
Citation: C. Gaser et al., Detecting structural changes in whole brain based on nonlinear deformations - Application to schizophrenia research, NEUROIMAGE, 10(2), 1999, pp. 107-113
Authors:
Riehemann, S
Volz, HP
Wenda, B
Hubner, G
Rossger, G
Rzanny, R
Sauer, H
Citation: S. Riehemann et al., Frontal lobe in vivo P-31-MRS reveals gender differences in healthy controls, not in schizophrenics, NMR BIOMED, 12(8), 1999, pp. 483-489
Authors:
Volz, HP
Gaser, C
Hager, F
Rzanny, R
Ponisch, J
Mentzel, HJ
Kaiser, WA
Sauer, H
Citation: Hp. Volz et al., Decreased frontal activation in schizophrenics during stimulation with thecontinuous performance test - a functional magnetic resonance imaging study, EUR PSYCHIA, 14(1), 1999, pp. 17-24
Authors:
Kreitschmann-Andermahr, I
Rosburg, T
Meier, T
Volz, HP
Nowak, H
Sauer, H
Citation: I. Kreitschmann-andermahr et al., Impaired sensory processing in male patients with schizophrenia: a magnetoencephalographic study of auditory mismatch detection, SCHIZOPHR R, 35(2), 1999, pp. 121-129
Authors:
Volz, HP
Hager, F
Citation: Hp. Volz et F. Hager, The use of functional imaging methods for the analysis of cognitive disorders, F NEUR PSYC, 1999, pp. S58-S63
Authors:
Maurer, I
Volz, HP
Sauer, H
Citation: I. Maurer et al., Gabapentin leads to remission of somatoform pain disorder with major depression, PHARMACOPS, 32(6), 1999, pp. 255-257
Authors:
Maurer, I
Volz, HP
Citation: I. Maurer et Hp. Volz, Lipid supplementation in schizophrenia, BR J PSYCHI, 175, 1999, pp. 287-288
Authors:
Volz, HP
Rossger, G
Riehemann, S
Hubner, G
Maurer, I
Wenda, B
Rzanny, R
Kaiser, WA
Sauer, H
Citation: Hp. Volz et al., Increase of phosphodiesters during neuroleptic treatment of schizophrenics: A longitudinal P-31-magnetic resonance spectroscopic study, BIOL PSYCHI, 45(9), 1999, pp. 1221-1225
Authors:
Volz, HP
Rzanny, R
Riehemann, S
May, S
Hegewald, H
Preussler, B
Hubner, G
Kaiser, WA
Sauer, H
Citation: Hp. Volz et al., P-31 magnetic resonance spectroscopy in the frontal lobe of major depressed patients, EUR ARCH PS, 248(6), 1998, pp. 289-295
Authors:
Volz, HP
Moller, HJ
Citation: Hp. Volz et Hj. Moller, Opipramol for the treatment of somatoform disorders - Results in controlled studies, F NEUR PSYC, 66, 1998, pp. S21-S24
Risultati:
1-25
|